The vaccine will not totally eliminate the risk of meningococcal disease, though it is highly effective against the four types of bacterial meningitis that account for about 70 to 80 percent of the cases of meningitis in college students. Rating Newest Oldest. Best Answer: The currently available meningococcal meningitis vaccine protects against four types of the bacterium Neisseria meningitidis, a very important cause of bacterial meningitis and sepsis in adolescents and young adults in the United States.